AZTR

Azitra Inc · AMEX

Sector Health Technology
Industry Pharmaceuticals: Major
Website azitrainc.com
Employees(FY) 10
ISIN US05479L2034

Performance

+10.47%

-35.23%

-45.41%

-63.83%

-34.55%

YTD

-99.23%

Profile

Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.

Advanced Technical Analysis

Technical Analysis of AZTR 2025-02-03

The stock indicators reflect a bearish sentiment, with a Moving Average Score of 16 and a Technical Score of 16, both indicating weakness, while the Oscillators Score of 50 suggests a neutral stance. Overall, the combined scores point to a lack of bullish momentum, signaling caution for potential investors.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of AZTR

Stock Rank

Recent News & Updates

2023-10-15 20:00
Azitra to Present at the ThinkEquity Conference(Yahoo Finance)
2023-08-28 20:00
Azitra to Present at the H.C. Wainwright 25th Annual Global Investment Conference(Yahoo Finance)
2023-08-14 04:05
Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates(Yahoo Finance)
2023-07-19 04:05
Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors(Yahoo Finance)
2023-07-11 04:05
Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer(Yahoo Finance)
2023-06-21 06:46
Azitra, Inc. Announces Closing of Initial Public Offering(Yahoo Finance)
2023-06-15 07:04
Azitra, Inc. Announces Pricing of Initial Public Offering(Yahoo Finance)

Page 2 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.